CD79A and cranioectodermal dysplasia: Altogether 311 IgA‐competent adults, with clinical suspicion or family history of CeD, underwent duodenal sampling and testing for TGA (ImmunoCAP EliA, cut‐off 7.0 U/mL) and endomysial antibodies (EmA).